BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 16099045)

  • 1. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.
    Shippenberg TS; LeFevour A; Chefer VI
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):442-53. PubMed ID: 19128202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of drug class on reward in substance use disorders.
    Jones JD; Arout CA; Luba R; Murugesan D; Madera G; Gorsuch L; Schusterman R; Martinez S
    Pharmacol Biochem Behav; 2024 Jul; 240():173771. PubMed ID: 38670466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.
    Engleman EA; Rodd ZA; Bell RL; Murphy JM
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):454-67. PubMed ID: 19128203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.
    Fernández-Ruiz J; Hernández M; Ramos JA
    CNS Neurosci Ther; 2010 Jun; 16(3):e72-91. PubMed ID: 20406253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the dopamine system.
    Söderpalm B; Ericson M
    Int Rev Neurobiol; 2024; 175():21-73. PubMed ID: 38555117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics.
    Salmanzadeh H; Ahmadi-Soleimani SM; Azadi M; Halliwell RF; Azizi H
    Curr Neuropharmacol; 2021; 19(9):1560-1569. PubMed ID: 33655865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible mechanism underlying the effectiveness of acupuncture in the treatment of drug addiction.
    Yang CH; Lee BH; Sohn SH
    Evid Based Complement Alternat Med; 2008 Sep; 5(3):257-66. PubMed ID: 18830420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neural basis of drug craving: an incentive-sensitization theory of addiction.
    Robinson TE; Berridge KC
    Brain Res Brain Res Rev; 1993; 18(3):247-91. PubMed ID: 8401595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
    Di Chiara G; Imperato A
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5274-8. PubMed ID: 2899326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain dopamine and reward.
    Wise RA; Rompre PP
    Annu Rev Psychol; 1989; 40():191-225. PubMed ID: 2648975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a common molecular pathway for addiction?
    Nestler EJ
    Nat Neurosci; 2005 Nov; 8(11):1445-9. PubMed ID: 16251986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction and brain reward and antireward pathways.
    Gardner EL
    Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.
    Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Childress AR; Jayne M; Ma Y; Wong C
    J Neurosci; 2006 Jun; 26(24):6583-8. PubMed ID: 16775146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive reward signal of dopamine neurons.
    Schultz W
    J Neurophysiol; 1998 Jul; 80(1):1-27. PubMed ID: 9658025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.
    Ikemoto S
    Neurosci Biobehav Rev; 2010 Nov; 35(2):129-50. PubMed ID: 20149820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.
    Everitt BJ; Robbins TW
    Nat Neurosci; 2005 Nov; 8(11):1481-9. PubMed ID: 16251991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling.
    Lüscher C; Malenka RC
    Neuron; 2011 Feb; 69(4):650-63. PubMed ID: 21338877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
    Leucht S; Cipriani A; Spineli L; Mavridis D; Orey D; Richter F; Samara M; Barbui C; Engel RR; Geddes JR; Kissling W; Stapf MP; Lässig B; Salanti G; Davis JM
    Lancet; 2013 Sep; 382(9896):951-62. PubMed ID: 23810019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amygdala is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior.
    Ziemann AE; Allen JE; Dahdaleh NS; Drebot II; Coryell MW; Wunsch AM; Lynch CM; Faraci FM; Howard MA; Welsh MJ; Wemmie JA
    Cell; 2009 Nov; 139(5):1012-21. PubMed ID: 19945383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.